Nuvation Bio
NUVB----
Nuvation Bio (NUVB)
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company’s lead product candida...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Nuvation Bio Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$12.3397.02%
Forecast & RatingStrong buy
10analysts
- Strong buy70.00%
- Buy20.00%
- Hold10.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 19 hours ago
AMC Entertainment, IREN, Hut 8 And Other Big Stocks Moving Higher On Monday
- PUBT · 21 hours ago
Nuvation Bio posts corporate deck highlighting IBTROZI ROS1+ NSCLC launch, safusidenib IDH1 glioma program
- StockTitan · 1 day ago, 11:00 PM
Nuvation Bio Announces Positive Updated Phase 2 Data and Expansion of Safusidenib Clinical Program with Two New Studies to Explore Broad Spectrum of IDH1-Mutant Glioma | NUVB Stock News
- Simplywall · Jul 13 at 04:12 PM
Is Nuvation Bio (NUVB) Fairly Valued Following UK Taletrectinib Filing Progress?
- Tip Ranks · Jul 9 at 04:29 PM
3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts
- StockTitan · Jul 6 at 08:09 AM
Nuvation Bio Inc. Announces Full Exercise of Greenshoe Option in $287.5 Million Convertible Senior Notes Offering | NUVB Stock News
